Towards Healthcare
Generic Drugs Market Size, Companies, Trends Report (2023 - 2032)

Generic Drugs Market Size Envisioned at USD 738.53 Billion by 2032

The report covers Generic Drugs Market Size and Companies segmented by drug class into simple generics, super generics and complex generics, by route of administration including oral, injectable, dermal and inhaler and by therapeutic application covering oncology, CNS, systemic anti-infectives, gastrointestinal, cardiovascular, musculoskeletal and others. Distribution channels comprise hospitals pharmacies, retail pharmacies and online pharmacies. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Generic Drugs Market Assessment

  • Overview
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Malaysia
      • Philippines
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of the Middle East & Africa

North America Generic Drugs Market Assessment

  • Overview
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.S.
    • Canada

Europe Generic Drugs Market Assessment

  • Overview
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.K.
    • Germany
    • France

Asia-Pacific Generic Drugs Market Assessment

  • Overview
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines

Latin America Generic Drugs Market Assessment

  • Overview
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • Brazil
    • Rest of Latin America

Middle East & Africa (MEA) Generic Drugs Market Assessment

  • Overview
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Company Profiles

  • Mylan N.V.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Abbott Laboratories
  • ALLERGAN
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • STADA Arzneimittel AG
  • GlaxoSmithKline Plc.
  • Baxter International Inc.
  • Pfizer Inc.
  • Sandoz International GmbH

Conclusion & Recommendations

  • Insight Code: 5053
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: June 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

The generic drugs market promotes competition, helps lower healthcare costs, and increases access to medications. It allows healthcare systems to allocate resources more efficiently and provides patients with more affordable treatment options.

Yes, generic drugs are held to the same rigorous standards of quality, safety, and efficacy as brand-name drugs. Regulatory authorities closely monitor and regulate the manufacturing and distribution of generic drugs to ensure they meet these standards.

The generic drugs market faces challenges such as market saturation, pricing pressures, complex regulatory processes, and the need for continuous research and development to stay competitive.

Department of Pharmaceuticals | Government of India

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509